StonvexLoading…
StonvexStonvexStonvexCore line items from GERN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $51.84M | $135.87M | $88.64M | $39.60M |
Operating Income | $158.00K | $-43.05M | $-29.16M | $-16.70M |
Net Income | $-3.64M | $-54.64M | $-16.38M | $-19.84M |
EPS (Diluted) | $-0.01 | $-0.08 | $-0.05 | $-0.03 |
Total Assets | $534.12M | $567.38M | $555.20M | $562.45M |
Total Liabilities | $305.01M | Not available | Not available | Not available |
Cash & Equivalents | $68.89M | $78.12M | $77.73M | $83.75M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 669.38K | 666.40M | 666.04M | 665.90K |